Multiple Manufacturers

ARALAST NP

Manufacturer:

Multiple Manufacturers

Aralast Np HCPCS:

J0256

HCPCS Code Descriptor:

Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg

Category:

J Code

Aralast Np NDCs:

00944-2814-01, 00944-2815-01, 13533-0705-01, 00053-7201-02, 13533-0700-02, 13533-0703-10, 13533-0701-01

Primary Type:

Pulmonary

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

13533-0701-01

About Aralast Np:

ARALAST NP is a Pulmonary drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J0256 is aligned to the drug ARALAST NP.

ACCESS PRICING AND MORE BY REGISTERING

J0256 Added Date:

January 1, 1989

J0256 Effective Date:

January 1, 2012

J0256 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Aralast Np billing and coding information.
Our team did not identify a source for Aralast Np patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for ARALAST NP
Our team has not yet identified a source of side effects information for ARALAST NP. Please check back in a few weeks.